+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars and Biosuperiors Market Research Reports

Biobetter Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

Biobetter Market - Forecasts from 2019 to 2024

  • Report
  • December 2019
  • 120 Pages
From
Technological Advances in Biobetter and Biosimilar Platforms - Product Thumbnail Image

Technological Advances in Biobetter and Biosimilar Platforms

  • Report
  • September 2019
  • 67 Pages
From
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - a 2017 Update - Product Thumbnail Image

Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - a 2017 Update

  • Report
  • November 2017
  • 58 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • June 2016
  • 462 Pages
From
Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors - Product Thumbnail Image

Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors

  • Report
  • June 2016
  • 1342 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies - 2016 Update

  • Report
  • May 2016
  • 84 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update

  • Report
  • May 2016
  • 124 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies - 2016 Update

  • Report
  • May 2016
  • 56 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies - 2016 Update

  • Report
  • May 2016
  • 74 Pages
From
Competitor Analysis: PTH Receptor Agonists 2016 and Teriparatide Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: PTH Receptor Agonists 2016 and Teriparatide Biosimilars and Biosuperiors

  • Report
  • February 2016
  • 32 Pages
From
Global & USA BioSimilar Market Analysis to 2021 - Product Thumbnail Image

Global & USA BioSimilar Market Analysis to 2021

  • Report
  • August 2015
  • 271 Pages
From
Charting the Biosimilar and Biobetter Development Pipeline (2013) - Product Thumbnail Image

Charting the Biosimilar and Biobetter Development Pipeline (2013)

  • Report
  • July 2013
  • 213 Pages
From
Charting the Biosimilar and Biobetter Development Pipeline - Product Thumbnail Image

Charting the Biosimilar and Biobetter Development Pipeline

  • Report
  • September 2012
  • 428 Pages
From
Biobetters: Major Players and Market Prospects (2nd edition) - Product Thumbnail Image

Biobetters: Major Players and Market Prospects (2nd edition)

  • Report
  • September 2011
  • 48 Pages
From
Generic and Biosimilar Pharmaceuticals (Global) - Industry Report - Product Thumbnail Image

Generic and Biosimilar Pharmaceuticals (Global) - Industry Report

  • Report
  • September 2020
  • 1210 Pages
From
Global Biosimilars Partnering Terms and Agreements 2010 to 2020 - Product Thumbnail Image

Global Biosimilars Partnering Terms and Agreements 2010 to 2020

  • Report
  • June 2020
  • 140 Pages
From
Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region - Global Forecast to 2025 - Product Thumbnail Image

Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region - Global Forecast to 2025

  • Report
  • March 2020
  • 187 Pages
From
Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 - Product Thumbnail Image

Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Report
  • January 2020
  • 232 Pages
From
Oral Biologics & Biosimilars Global Market Opportunities and Strategies to 2030 - Product Thumbnail Image

Oral Biologics & Biosimilars Global Market Opportunities and Strategies to 2030

  • Report
  • October 2020
  • 317 Pages
From
Interferon - Biosimilar Insight, 2020 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2020

  • Report
  • August 2020
  • 70 Pages
From
Loading Indicator
adroll